You are not logged in.
Login to update your contact information or edit your email preferences, or Register to create an account.
The House Agriculture Appropriations Committee has released
a report that, among other things, chastises the FDA for stalling on the
rewrite of their New Dietary Ingredient (NDI) guidance. The committee directed
the FDA to end this “regulatory uncertainty,” issue a timeline for the NDI
guidance, and include stakeholders in the process.
The FDA has been dragging its feet on the NDI draft guidance.
It has been close to two years since FDA submitted its initial draft guidance,
and the agency has been promising to create a second draft of it since October 2012
-- eight months ago! An uncertain regulatory environment is bad for business,
innovation will be stifled, and consumers will be the losers.
Thank the committee members—in particular, the committee
chair, Rep. Robert Aderholt (R-AL), and its ranking member, Rep. Sam Farr
(D-CA), for their leadership—for including this important charge to FDA in
their report. (Because this Action Alert is being sent only to the committee
members, rather than the whole House, you will see a message if you don’t live
in one of the committee members’ states.)
Please personalize and add your own comments if you have time!
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]